Right Decisions
DGRefHelp - NHS Dumfries & Galloway
Sexual health
Post-exposure prophylaxis for HIV
Back
PEP after sexual exposure - information for clinicians
What information do I need to help counsel the patient about PEP?

Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

What information do I need to help counsel the patient about PEP?

DGRefHelp - NHS Dumfries & Galloway

NHS Dumfries and Galloway

When did the exposure occur? (once 72 hrs are over PEP won’t usually be offered)
What type(s) of sex occurred, including the use of condoms?
Was there any bleeding or trauma?
Was the sex consensual?
Is the index partner known to be HIV positive?
Does either partner have an existi g sexually transmitted infection?
Is the index partner from a high prevalence country/risk group (for example a man who has sex with men, someone who has migrated to the UK from a country where HIV is a lot more common or an intravenous drug user from high risk countries especially Eastern Europe and Central Asia?
The patient’s general health?
The patient’s medications (including herbal remedies) that might interact with PEP? See http://www.hiv-druginteractions.org
For female patients, could she be pregnant?